• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导神经干细胞对帕金森病的治疗潜力

Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.

作者信息

Choi Dong-Hee, Kim Ji-Hye, Kim Sung Min, Kang Kyuree, Han Dong Wook, Lee Jongmin

机构信息

Department of Medical Science, School of Medicine, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Korea.

Center for Neuroscience Research, Institute of Biomedical Science and Technology, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Korea.

出版信息

Int J Mol Sci. 2017 Jan 22;18(1):224. doi: 10.3390/ijms18010224.

DOI:10.3390/ijms18010224
PMID:28117752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5297853/
Abstract

Parkinson's disease (PD) is a chronic, neurodegenerative disorder that results from the loss of cells in the substantia nigra (SN) which is located in the midbrain. However, no cure is available for PD. Recently, fibroblasts have been directly converted into induced neural stem cells (iNSCs) via the forced expression of specific transcription factors. Therapeutic potential of iNSC in PD has not been investigated yet. Here, we show that iNSCs directly converted from mouse fibroblasts enhanced functional recovery in an animal model of PD. The rotational behavior test was performed to assess recovery. Our results indicate that iNSC transplantation into the striatum of 6-hydroxydopamine (6-OHDA)-injected mice can significantly reduce apomorphine-induced rotational asymmetry. The engrafted iNSCs were able to survive in the striatum and migrated around the medial forebrain bundle and the SN pars compacta. Moreover, iNSCs differentiated into all neuronal lineages. In particular, the transplanted iNSCs that committed to the glial lineage were significantly increased in the striatum of 6-OHDA-injected mice. Engrafted iNSCs differentiated to dopaminergic (DA) neurons and migrated into the SN in the 6-OHDA lesion mice. Therefore, iNSC transplantation serves as a valuable tool to enhance the functional recovery in PD.

摘要

帕金森病(PD)是一种慢性神经退行性疾病,由位于中脑的黑质(SN)中的细胞丢失所致。然而,目前尚无治愈PD的方法。最近,通过强制表达特定转录因子,成纤维细胞已被直接转化为诱导神经干细胞(iNSCs)。iNSC在PD中的治疗潜力尚未得到研究。在此,我们表明从小鼠成纤维细胞直接转化而来的iNSCs可增强PD动物模型的功能恢复。通过旋转行为测试来评估恢复情况。我们的结果表明,将iNSC移植到注射了6-羟基多巴胺(6-OHDA)的小鼠纹状体中可显著降低阿扑吗啡诱导的旋转不对称性。移植的iNSCs能够在纹状体中存活,并在内侧前脑束和黑质致密部周围迁移。此外,iNSCs分化为所有神经元谱系。特别是,在注射了6-OHDA的小鼠纹状体中,分化为胶质谱系的移植iNSCs显著增加。在6-OHDA损伤小鼠中,移植的iNSCs分化为多巴胺能(DA)神经元并迁移到黑质中。因此,iNSC移植是增强PD功能恢复的一种有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/93940c31148d/ijms-18-00224-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/08bf4106113b/ijms-18-00224-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/c258135c7b2d/ijms-18-00224-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/ddaaa9e9ece5/ijms-18-00224-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/31725764b24c/ijms-18-00224-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/fd5f436934e2/ijms-18-00224-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/4fba37945fb0/ijms-18-00224-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/93940c31148d/ijms-18-00224-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/08bf4106113b/ijms-18-00224-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/c258135c7b2d/ijms-18-00224-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/ddaaa9e9ece5/ijms-18-00224-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/31725764b24c/ijms-18-00224-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/fd5f436934e2/ijms-18-00224-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/4fba37945fb0/ijms-18-00224-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/695c/5297853/93940c31148d/ijms-18-00224-g007.jpg

相似文献

1
Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.诱导神经干细胞对帕金森病的治疗潜力
Int J Mol Sci. 2017 Jan 22;18(1):224. doi: 10.3390/ijms18010224.
2
Lmx1a enhances the effect of iNSCs in a PD model.Lmx1a增强了诱导性神经干细胞(iNSCs)在帕金森病(PD)模型中的作用。
Stem Cell Res. 2015 Jan;14(1):1-9. doi: 10.1016/j.scr.2014.10.004. Epub 2014 Oct 18.
3
Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson's disease.通过 DREADD 对人诱导多能干细胞源性多巴胺能神经元的调制揭示了其对帕金森病小鼠模型的治疗效果。
Stem Cell Res Ther. 2024 Sep 11;15(1):297. doi: 10.1186/s13287-024-03921-y.
4
Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.人诱导多能干细胞衍生的神经元改善6-羟基多巴胺诱导的帕金森病大鼠模型中的运动不对称。
Cytotherapy. 2015 May;17(5):665-79. doi: 10.1016/j.jcyt.2015.02.001. Epub 2015 Mar 5.
5
Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.人胎盘源神经细胞对帕金森病模型鼠的神经保护作用及神经炎症抑制的双重影响。
Cell Transplant. 2018 May;27(5):814-830. doi: 10.1177/0963689718766324. Epub 2018 Jun 5.
6
Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.人血诱导多能干细胞分化的多巴胺能前体细胞改善了帕金森病模型小鼠的症状。
Theranostics. 2018 Sep 9;8(17):4679-4694. doi: 10.7150/thno.26643. eCollection 2018.
7
Neural stem cells transplanted in a mouse model of Parkinson's disease differentiate to neuronal phenotypes and reduce rotational deficit.神经干细胞移植到帕金森病小鼠模型中可分化为神经元表型,并减少旋转运动缺陷。
CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):829-35. doi: 10.2174/1871527311201070829.
8
Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.神经干细胞移植联合硬脂酸乙酯通过促进神经干细胞迁移和分化改善 PD 大鼠的运动行为。
CNS Neurosci Ther. 2023 Jun;29(6):1571-1584. doi: 10.1111/cns.14119. Epub 2023 Mar 16.
9
Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.在帕金森病临床前体内模型中VEGF-B和GDNF引发的神经营养作用的比较研究。
Neuroscience. 2014 Jan 31;258:385-400. doi: 10.1016/j.neuroscience.2013.11.038. Epub 2013 Nov 27.
10
Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease.移植的原代星形胶质细胞 2 型可改善帕金森病大鼠模型黑质纹状体通路的恢复。
Mol Cell Biochem. 2021 Feb;476(2):619-631. doi: 10.1007/s11010-020-03931-3. Epub 2020 Oct 17.

引用本文的文献

1
Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases.用于治疗神经退行性疾病的基于细胞的再生和年轻化策略。
Stem Cell Res Ther. 2025 Apr 6;16(1):167. doi: 10.1186/s13287-025-04285-7.
2
Emerging Pro-neurogenic Therapeutic Strategies for Neurodegenerative Diseases: A Review of Pre-clinical and Clinical Research.神经退行性疾病新兴的促神经发生治疗策略:临床前和临床研究综述
Mol Neurobiol. 2025 Jan;62(1):46-76. doi: 10.1007/s12035-024-04246-w. Epub 2024 May 31.
3
Progress in direct reprogramming of dopaminergic cell replacement therapy.

本文引用的文献

1
Generation of Integration-free Induced Neural Stem Cells from Mouse Fibroblasts.从小鼠成纤维细胞中生成无整合诱导神经干细胞。
J Biol Chem. 2016 Jul 1;291(27):14199-14212. doi: 10.1074/jbc.M115.713578. Epub 2016 May 4.
2
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis.帕金森病的发病率:一项系统评价与荟萃分析
Neuroepidemiology. 2016;46(4):292-300. doi: 10.1159/000445751. Epub 2016 Apr 23.
3
Induced neural stem cells from distinct genetic backgrounds exhibit different reprogramming status.来自不同遗传背景的诱导神经干细胞表现出不同的重编程状态。
多巴胺能细胞替代疗法直接重编程的进展。
Neurol Sci. 2024 Mar;45(3):873-881. doi: 10.1007/s10072-023-07175-z. Epub 2023 Nov 10.
4
Systems biology approach discovers comorbidity interaction of Parkinson's disease with psychiatric disorders utilizing brain transcriptome.系统生物学方法利用大脑转录组发现帕金森病与精神障碍的共病相互作用。
Front Mol Neurosci. 2023 Aug 16;16:1232805. doi: 10.3389/fnmol.2023.1232805. eCollection 2023.
5
Characterization of Human-Induced Neural Stem Cells and Derivatives following Transplantation into the Central Nervous System of a Nonhuman Primate and Rats.人诱导神经干细胞及其衍生物移植到非人灵长类动物和大鼠中枢神经系统后的特征分析
Stem Cells Int. 2022 Dec 28;2022:1396735. doi: 10.1155/2022/1396735. eCollection 2022.
6
Neural stem cell therapy for brain disease.用于脑部疾病的神经干细胞疗法。
World J Stem Cells. 2021 Sep 26;13(9):1278-1292. doi: 10.4252/wjsc.v13.i9.1278.
7
Oxidative-Signaling in Neural Stem Cell-Mediated Plasticity: Implications for Neurodegenerative Diseases.神经干细胞介导的可塑性中的氧化信号传导:对神经退行性疾病的影响
Antioxidants (Basel). 2021 Jul 6;10(7):1088. doi: 10.3390/antiox10071088.
8
Urine-derived induced pluripotent/neural stem cells for modeling neurological diseases.用于神经系统疾病建模的尿液来源诱导多能/神经干细胞
Cell Biosci. 2021 May 13;11(1):85. doi: 10.1186/s13578-021-00594-5.
9
Induced neural stem cells from human patient-derived fibroblasts attenuate neurodegeneration in Niemann-Pick type C mice.人源成纤维细胞诱导的神经干细胞减轻尼曼-匹克 C 型小鼠的神经退行性变。
J Vet Sci. 2021 Jan;22(1):e7. doi: 10.4142/jvs.2021.22.e7.
10
Xeno- and transgene-free reprogramming of mesenchymal stem cells toward the cells expressing neural markers using exosome treatments.使用外泌体处理实现对间充质干细胞进行无异种和转基因的重编程,使其表达神经标记物。
PLoS One. 2020 Oct 13;15(10):e0240469. doi: 10.1371/journal.pone.0240469. eCollection 2020.
Stem Cell Res. 2016 Mar;16(2):460-8. doi: 10.1016/j.scr.2016.02.025. Epub 2016 Feb 10.
4
Cognitive Impairment Associated with Parkinson's Disease: Role of Mitochondria.帕金森病相关的认知障碍:线粒体的作用
Curr Neuropharmacol. 2016;14(6):584-92. doi: 10.2174/1570159x14666160104142349.
5
Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.帕金森病的细胞疗法:重编程技术带来的新希望
Aging Dis. 2015 Nov 17;6(6):499-503. doi: 10.14336/AD.2014.1201. eCollection 2015 Nov.
6
Stem cell transplantation therapy in Parkinson's disease.帕金森病的干细胞移植治疗
Springerplus. 2015 Oct 13;4:597. doi: 10.1186/s40064-015-1400-1. eCollection 2015.
7
Development of stem cell-based therapy for Parkinson's disease.基于干细胞的帕金森病治疗的发展。
Transl Neurodegener. 2015 Sep 3;4:16. doi: 10.1186/s40035-015-0039-8. eCollection 2015.
8
Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease.人脂肪来源干细胞对帕金森病小鼠模型的治疗潜力
Neurobiol Aging. 2015 Oct;36(10):2885-92. doi: 10.1016/j.neurobiolaging.2015.06.022. Epub 2015 Jun 24.
9
A partial lesion model of Parkinson's disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion.小鼠帕金森病部分损伤模型——6-羟基多巴胺诱导的内侧前脑束损伤的特征
Behav Brain Res. 2015 May 1;284:196-206. doi: 10.1016/j.bbr.2015.01.053. Epub 2015 Feb 16.
10
Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition.基于 iPSC 的细胞疗法在脊髓损伤模型中的长期安全性问题:上皮-间充质转化的致癌转化。
Stem Cell Reports. 2015 Mar 10;4(3):360-73. doi: 10.1016/j.stemcr.2015.01.006. Epub 2015 Feb 13.